These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 15235686

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Duration of anticoagulant therapy after initial idiopathic venous thromboembolism.
    Frazee LA, Chomo DL.
    Ann Pharmacother; 2003 Oct; 37(10):1489-96. PubMed ID: 14519045
    [Abstract] [Full Text] [Related]

  • 23. Long-term anticoagulation for venous thromboembolism: duration of treatment and management of warfarin therapy.
    Kearon C.
    Clin Chest Med; 2010 Dec; 31(4):719-30. PubMed ID: 21047578
    [Abstract] [Full Text] [Related]

  • 24. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
    Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S.
    N Engl J Med; 2000 Aug 17; 343(7):457-62. PubMed ID: 10950667
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.
    Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H.
    N Engl J Med; 1995 Jun 22; 332(25):1661-5. PubMed ID: 7760866
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Long-term management of patients after venous thromboembolism.
    Kearon C.
    Circulation; 2004 Aug 31; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, Geerts W, LeClerc J, Neemeh J, Powers P.
    Thromb Haemost; 1995 Aug 31; 74(2):606-11. PubMed ID: 8584992
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.
    Palareti G, Legnani C, Lee A, Manotti C, Hirsh J, D'Angelo A, Pengo V, Moia M, Coccheri S.
    Thromb Haemost; 2000 Nov 31; 84(5):805-10. PubMed ID: 11127860
    [Abstract] [Full Text] [Related]

  • 39. The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group.
    Schulman S.
    Wien Med Wochenschr; 1999 Nov 31; 149(2-4):66-9. PubMed ID: 10378327
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.